Volume 3, Issue 1, Page 12 (January 2008)
15 of 40
PREVIEW
FULL TEXT
FULL-TEXT PDF (218 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
Thiazolidinediones, primarily rosiglitazone, were associated with a significant increase in the risk of congestive heart failure, myocardial infarction, and mortality in a large study of older patients with diabetes.
PII: S1558-0164(08)70015-4
doi:10.1016/S1558-0164(08)70015-4
© 2008 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
PREVIEW